Electromed, Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter Ended June 30, 2021
August 09, 2021 at 05:05 pm
Share
Electromed, Inc. provided preliminary unaudited earnings guidance for the fourth quarter ended June 30, 2021. For the quarter, the company expects to report net revenue of between $9.3 million and $9.5 million, compared to $6.9 million for the three months ended June 30, 2020, driven primarily by strong growth in home care revenue. Operating income of between $0.5 million and $0.7 million, compared to $1.3 million in fourth quarter of Fiscal Year 2020.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
ELECTROMED, INC. 
